Post Job

TerSera Therapeutics CEO and Executives

Executive Summary. Based on our data team's research, Edward J. Fiorentino is the TerSera Therapeutics's CEO. TerSera Therapeutics has 135 employees, of which 13 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The TerSera Therapeutics executive team is 23% female and 77% male.
  • 69% of the management team is White.
  • 9% of TerSera Therapeutics management is Hispanic or Latino.
  • 11% of the management team is Black or African American.
Work At TerSera Therapeutics?
Share Your Experience

Rate TerSera Therapeutics' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Edward J. Fiorentino

Chairman and Chief Executive Officer

Nancy Joseph Ridge

EVP R&D and Chief Medical Officer at Tersera

Nancy Joseph Ridge's LinkedIn

Nancy has more than 25 years of experience in academic clinical research and the pharmaceutical industry. Previously, Nancy was at Takeda with senior level management experience that included being a Corporate Officer and an R&D Executive. She was head of CNS, Immunology and Rheumatology therapeutic areas, responsible for all strategic aspects of R&D for those areas. She was also head of Global Development and was responsible for all aspects of drug development of pipeline and marketed compounds, including clinical sciences, clinical operations, medical, regulatory, pharmacovigilance, project management and quality.

Prior to that, Nancy was President Takeda Global R&D U.S., Vice-President of R&D at TAP Pharmaceuticals, and she held various positions in clinical development at Searle/Pharmacia.

Prior to working in the pharmaceutical industry, she was an Assistant Professor of Medicine at Rush Medical Center and an Assistant Professor of Clinical Medicine at University of Chicago.

Nancy previously served on the Board of iBIO Institute and was chairperson for two years. She also served on the PhRMA Scientific and Regulatory Committee and Chicago Technology Industry Diversity Council.

Nancy received her medical degree from University of Illinois, completed internship and residency in Internal Medicine and was chief resident at Rush Medical Center and then completed fellowship in Rheumatology at University of Chicago. She received Board certifications in Internal Medicine and Rheumatology. Nancy has been a member of various professional societies and is currently a Fellow Member of the American College of Rheumatology.

Benjamin J. Daverman

Board Member

Charlie Tobler

Executive Vice President

Charlie Tobler's LinkedIn

Mark Tatro

EVP & Chief Financial Officer

Mark Tatro's LinkedIn

Senior business executive that has led two organizations from start-up to acquisition by strategic buyers, providing superior financial returns to investors. Extensive background in private equity and VC financed business models as well as IPO and public markets. In-depth experience in mergers and acquisitions, financings, investor relations, treasury, taxation, working capital management and cash flow planning. Proven business partner in strategic planning, budgeting and business modeling. Strong skills in business operations, accounting, internal and external financial reporting and internal controls.

Main goal is to leverage current commercial leadership experience and extensive finance background to become a Chief Financial Officer.

Specialties: Strong skills in accounting, financial reporting and internal controls. In-depth experience in investor relations, treasury, taxation, mergers and acquisitions, financings and working capital management

Vicky Papoutsis

Executive Vice President

Bryan Reiners

Executive Vice President

Dean S. Mihas

Board Member

Edward Donovan

President

John C. Landgraf

Retired Abbott Executive

Do you work at TerSera Therapeutics?

Does the leadership team provide a clear direction for TerSera Therapeutics?

TerSera Therapeutics Jobs

TerSera Therapeutics Board Members

Name & TitleBio
Nancy Joseph Ridge

EVP R&D and Chief Medical Officer at Tersera

Nancy Joseph Ridge's LinkedIn

Nancy has more than 25 years of experience in academic clinical research and the pharmaceutical industry. Previously, Nancy was at Takeda with senior level management experience that included being a Corporate Officer and an R&D Executive. She was head of CNS, Immunology and Rheumatology therapeutic areas, responsible for all strategic aspects of R&D for those areas. She was also head of Global Development and was responsible for all aspects of drug development of pipeline and marketed compounds, including clinical sciences, clinical operations, medical, regulatory, pharmacovigilance, project management and quality.

Prior to that, Nancy was President Takeda Global R&D U.S., Vice-President of R&D at TAP Pharmaceuticals, and she held various positions in clinical development at Searle/Pharmacia.

Prior to working in the pharmaceutical industry, she was an Assistant Professor of Medicine at Rush Medical Center and an Assistant Professor of Clinical Medicine at University of Chicago.

Nancy previously served on the Board of iBIO Institute and was chairperson for two years. She also served on the PhRMA Scientific and Regulatory Committee and Chicago Technology Industry Diversity Council.

Nancy received her medical degree from University of Illinois, completed internship and residency in Internal Medicine and was chief resident at Rush Medical Center and then completed fellowship in Rheumatology at University of Chicago. She received Board certifications in Internal Medicine and Rheumatology. Nancy has been a member of various professional societies and is currently a Fellow Member of the American College of Rheumatology.

Benjamin J. Daverman

Board Member

Dean S. Mihas

Board Member

TerSera Therapeutics Executives FAQs

Zippia gives an in-depth look into the details of TerSera Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about TerSera Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at TerSera Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by TerSera Therapeutics. The data presented on this page does not represent the view of TerSera Therapeutics and its employees or that of Zippia.

TerSera Therapeutics may also be known as or be related to TerSera Therapeutics, TerSera Therapeutics LLC and Tersera Therapeutics.